Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine

Inclusion Criteria

• •Patient with at least 1-year history of migraines (with or without aura) including the following:
• •* Migraine attacks more than 1 year with age of onset prior to 50 years of age
• •* Migraine attacks, on average, last about 4 - 72 hours if untreated
• •* No more than 8 attacks of moderate to severe intensity per month within last 3 months
• •* Patient must be able to distinguish migraine attacks from tension/cluster attacks and must have consistent migraine headaches of at least 2 migraine headaches attacks of moderate to severe intensity in each of the last 3 months
• •* Less than 15 days of headache (migraine or non-migraine) per month in each of 3 months prior to screening
• •Male and female ≥ 18 years and ≤ age 65
• •No clinically significant abnormality identified on the medical or laboratory evaluation